NCT06781515
- Conditions
- Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- IRCCS Azienda Ospedaliero - Universitaria di Bologna Bologna, Italy
Clinical trial condition
Leukemia, Hairy Cell
Explore clinical trials studying Leukemia, Hairy Cell. Study availability and eligibility vary by location and protocol.
171 public trials
14 recruiting studies
Leukemia, Hairy Cell trial results
NCT06774677
- Conditions
- Hairy Cell Leukemia (HCL), Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello Palermo, PA, Italy
- Policlinico Santa Maria alla Scotte Siena, SI, Italy
- IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
NCT06764524
- Conditions
- Hairy Cell Leukemia (HCL), Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
NCT02131753
- Conditions
- Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Community based hemato-oncology medical office Ansbach, Germany
- Community based hemato-oncology medical office Aschaffenburg, Germany
- Rhön-Saale-Klinik gGmbH Bad Neustadt an der Saale, Germany
- Community based hemato-oncology medical office Berlin, Germany
Not yet recruiting
Innovative 3D Preclinical Models for Mature B-cell Malignancies to Advance Personalized Immuno and Combination Therapies
NCT07759661
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +17 more
- Locations
-
- IRCCS Ospedale San Raffaele Milan, MI, Italy
NCT07679919
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
- Locations
-
- Taussig Cancer Institute | Cleveland Clinic Cleveland, Ohio, United States
Enrolling by invitation
Rituximab+ Zanubrutinib for Patients With Hairy Cell Leukemia and Hairy Cell Variant
NCT07690761
- Conditions
- Hairy Cell Leukemia, Hairy Cell Leukemia Variant, Hematologic Diseases, +9 more
- Locations
-
- Bnai Zion Haifa, Israel
Active, not recruiting
Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia
NCT01841723
- Conditions
- Hairy Cell Leukemia, Hairy Cell Leukemia Variant, Hematologic Diseases, +11 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, not recruiting
Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia
NCT06311227
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- City of Hope at Irvine Lennar Irvine, California, United States
- UM Sylvester Comprehensive Cancer Center at Aventura Aventura, Florida, United States
- UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
Active, not recruiting
A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia
NCT03410875
- Conditions
- Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Yale University New Haven, Connecticut, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States